Novelix Pharmaceuticals Ltd Share Price
As on 18 November 2025 at 23:47 IST
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
44.14%
Over 6 Months
127.77%
Over 1 Year
176.70%
Over 3 Years
573.44%
Novelix Pharmaceuticals Ltd Summary
Close ₹63.64
Open ₹63.60
High ₹63.64
Low ₹63.60
Volume 13,249
Net Turnover (in Cr) ₹0.084
52Wk High ₹63.64
52Wk Low ₹23
52Wk High / Low
23
63.64
Novelix Pharmaceuticals Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹102.72
EPS (TTM) 0.60
Book Value (BV) 17.92
Div. Yield -
P/E (TTM) 106.07
Price/Book Value 3.55
Delivery % 100 %
Face Value 10
Key Ratios
PE Ratio 332.63
PB Ratio 1.51
EV to Sales 0.84
PEG Ratio 0.48
ROA 0.46
ROE 0.56
Debt-Equity -
Net Profit Margin 0.26
Operating Profit Margin 0.52
Novelix Pharmaceuticals Ltd Financials
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Total Revenue | 9.16 | 9.59 | 10.85 | 10.84 | 10.71 |
| Total Expenses | 11.28 | 13.31 | 11.06 | 10.96 | 10.91 |
| Profit Before Tax | -2.03 | -3.75 | -0.21 | -0.12 | -0.21 |
| Profit After Tax | -2.03 | -3.76 | -0.26 | -0.15 | -0.35 |
| Operating Profit After Depreciation | -2.12 | -3.73 | -0.21 | -0.12 | -0.20 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Fixed Assets | 0.47 | 1,652.83 | 1.83 | 1.92 | 2.17 |
| Total Non Current Assets | 2.81 | 2.24 | 2.33 | 2.62 | 3.02 |
| Total Current Assets | 5.93 | 7.33 | 11.39 | 10.72 | 10.56 |
| Total Assets | 8.74 | 9.57 | 13.72 | 13.34 | 13.58 |
| Total Shareholder's Fund | 7.40 | 6.86 | 10.60 | 10.92 | 11.17 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 1.59 | 1.59 | 0.63 | -0.53 | 0.37 |
| Net Cash Used In Investing Activities | -0.76 | 0.14 | 0.45 | 0.43 | -0.64 |
| Net Cash Used In Financing Activities | - | -0.77 | -0.16 | -0.05 | 0.02 |
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 30.73 | 4.53 | 1.92 | 1.39 | 1.31 |
| Total Expenses | 30.61 | 4.51 | 1.98 | 2.96 | 4.58 |
| Profit Before Tax | 0.12 | 0.02 | -0.06 | -1.57 | -3.27 |
| Profit After Tax | 0.08 | 0.01 | -0.06 | -1.56 | -3.27 |
| Operating Profit After Depreciation | 0.12 | 0.02 | -0.06 | -1.57 | -3.27 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 0.19 | 0.12 | 0.17 | 0.23 | 0.22 |
| Total Non Current Assets | 0.27 | 3.24 | 3.01 | 2.62 | 4.07 |
| Total Current Assets | 26.93 | 4.13 | 4.24 | 4.63 | 4.70 |
| Total Assets | 27.21 | 7.36 | 7.26 | 7.25 | 8.77 |
| Total Shareholder's Fund | 17.54 | 7.35 | 7.20 | 7.24 | 8.80 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | -13.68 | -0.34 | -2.41 | 0.59 | 0.58 |
| Net Cash Used In Investing Activities | 2.93 | 0.19 | 0.08 | 0.28 | 0.21 |
| Net Cash Used In Financing Activities | 11.32 | - | - | - | - |
| Particulars (in ₹ Cr.) | 2022-09 | 2022-06 | 2022-03 | 2021-12 | 2021-09 |
|---|---|---|---|---|---|
| Total Revenue | 1.24 | 1.36 | 0.69 | 1.11 | 2.46 |
| Total Expenses | 1.43 | 1.50 | 2.32 | 2.09 | 2.31 |
| Profit Before Tax | -0.15 | -0.08 | -1.48 | -0.95 | 0.44 |
| Profit After Tax | -0.15 | -0.09 | -1.57 | -0.74 | 0.35 |
| Operating Profit after Depreciation | -0.13 | -0.06 | -1.51 | -0.91 | 0.48 |
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 36.36 | 22.35 | 20.86 | 5.30 | 3.96 |
| Total Expenses | 35.66 | 22.17 | 20.63 | 5.17 | 3.74 |
| Profit Before Tax | 0.72 | 0.17 | 0.21 | 0.13 | 0.14 |
| Profit After Tax | 0.53 | 0.11 | 0.18 | 0.15 | 0.13 |
| Operating Profit after Depreciation | 0.73 | 0.18 | 0.23 | 0.13 | 0.14 |
Novelix Pharmaceuticals Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 63.61
S2 63.59
S3 63.57
Pivot 63.63
R1 63.65
R2 63.67
R3 63.69
Moving Average
20 SMA 52.64
50 SMA 45.32
100 SMA 43.58
200 SMA 31.02
Novelix Pharmaceuticals Ltd Corporate Actions
No available data
Novelix Pharmaceuticals Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,763.70 | ₹4,23,170.71 |
| Divis Laboratories Ltd | ₹6,523.25 | ₹1,73,171.79 |
| Torrent Pharmaceuticals Ltd | ₹3,816.75 | ₹1,29,170.36 |
| Cipla Ltd | ₹1,536.25 | ₹1,24,093.85 |
| Dr Reddys Laboratories Ltd | ₹1,244.50 | ₹1,03,868.61 |
Novelix Pharmaceuticals Ltd Top Mutal Funds Invested
No data available
Novelix Pharmaceuticals Ltd News
Novelix Pharmaceuticals to convene board meeting
On 13 November 2025
10 Nov 2025, 10:45 am
Novelix Pharmaceuticals to conduct AGM
On 19 September 2025
16 Aug 2025, 10:05 am
Novelix Pharmaceuticals to announce Quarterly Result
On 14 August 2025
09 Aug 2025, 03:10 pm
Novelix Pharmaceuticals to conduct board meeting
On 24 June 2025
21 Jun 2025, 03:28 pm
Novelix Pharmaceuticals to convene board meeting
On 27 May 2025
21 May 2025, 04:50 pm
Novelix Pharmaceuticals Ltd Stock Analysis
- Annual revenue for Novelix Pharmaceuticals Ltd increased by 578.29% to ₹30.73 crore in FY 2025 from ₹4.53 crore in FY 2024.
- Annual Net Profit for Novelix Pharmaceuticals Ltd increased by 711.76% to ₹0.08 crore in FY 2025 from ₹0.01 crore in FY 2024.
- Promoter Shareholding in Novelix Pharmaceuticals Ltd remains unchanged by 0.00% in the most recent quarter, from 54.82% in September 2025 to 54.82% in November 2025.
- Novelix Pharmaceuticals Ltd delivered a 1-year return of 176.70% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
- Novelix Pharmaceuticals Ltd share price moved up by 5.00% from its previous close of INR ₹63.64. The latest Novelix Pharmaceuticals Ltd share price is INR ₹66.82.
- Novelix Pharmaceuticals Ltd share price today has been at a low of 66.82 and a high of 66.82. Over the past 52 weeks, the Novelix Pharmaceuticals Ltd share price has seen a low of 23 and a high of 66.82.
FAQ’s
What is the share price of Novelix Pharmaceuticals Ltd today?
Novelix Pharmaceuticals Ltd share price as on 18 Nov 2025 is ₹ 66.82
What is the Market Cap of Novelix Pharmaceuticals Ltd?
The market cap of Novelix Pharmaceuticals Ltd stock is ₹102.72 Cr.
What is the PE Ratio of Novelix Pharmaceuticals Ltd?
The Price to Earnings (P/E) Ratio of Novelix Pharmaceuticals Ltd is 332.63
What is the PB Ratio of Novelix Pharmaceuticals Ltd?
The Price to Book (P/B) Ratio of Novelix Pharmaceuticals Ltd is 1.51
What is the 52 week high of Novelix Pharmaceuticals Ltd Share Price?
The 52 week high of Novelix Pharmaceuticals Ltd share price stands at ₹63.64
What is the 52 week low of Novelix Pharmaceuticals Ltd Share Price?
The 52 week low of Novelix Pharmaceuticals Ltd share price stands at ₹23
How can I buy shares of Novelix Pharmaceuticals Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Novelix Pharmaceuticals Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
